Literature DB >> 9302348

MDL-28170, a membrane-permeant calpain inhibitor, attenuates stunning and PKC epsilon proteolysis in reperfused ferret hearts.

F Urthaler1, P E Wolkowicz, S B Digerness, K D Harris, A A Walker.   

Abstract

OBJECTIVES: This paper tests the hypothesis that calpains are activated in the ischemic (I)/reperfused (R) heart and contribute to myocardial stunning.
METHODS: Isolated ferret hearts were Langendorff perfused isovolumically, and subjected to 20 min of global I followed by 30 min of R in the presence or absence of 0.2 microM MDL-28170, a membrane-permeant calpain inhibitor. Right trabeculae then were isolated from these hearts, skinned chemically, and pCa(2+)-force curves obtained. Samples of left ventricle were extracted subjected to SDS-PAGE, and Western analyzed for PKC epsilon and PKM epsilon.
RESULTS: Perfused ferret hearts exhibit a 43% decline in left ventricular developed pressure during R. Pre-treatment of hearts with MDL-28170 prior to I significantly improves function during R. Trabecular myofilaments from normal hearts have a KD for Ca2+ of 6.27 +/- 0.06; I/R decreased the KD to 6.09 +/- 0.04; trabeculae from I/R hearts pre-treated with MDL-28170 have a KD of 6.28 +/- 0.04. Western analysis shows ferret hearts to contain a single approximately equal to 96 kDa species of PKC epsilon. I/R hearts contain the native PKC epsilon and a approximately equal to 25 kDa smaller species of PKC epsilon which corresponds to PKM epsilon, the calpain proteolyzed form of PKC epsilon. Pre-treatment of I/R hearts with MDL-28170 markedly diminishes PKM epsilon in reperfused hearts.
CONCLUSIONS: Mechanical stunning during R is sensitive to MDL-28170. Depressed mechanical function is reflected in a hyposensitization of trabecular myofilaments to Ca2+. Western analysis shows that PKM epsilon is present in R hearts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302348     DOI: 10.1016/s0008-6363(97)00099-0

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  15 in total

1.  Protein kinase C expression and subcellular distribution in chronic myocardial ischemia. Comparison of two different canine models.

Authors:  M Matejovicova; B Shivalkar; J Vanhaecke; M Szilard; W Flameng
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

2.  Calpain, calpastatin activities and ratios during myocardial ischemia-reperfusion.

Authors:  D Enns; M Karmazyn; J Mair; A Lercher; J Kountchev; A Belcastro
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

3.  Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor.

Authors:  S Sandmann; M Yu; T Unger
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes.

Authors:  C Kositprapa; B Zhang; S Berger; J M Canty; T C Lee
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

5.  Role of protein kinase C in the reduction of infarct size by N-methyl-1-deoxynojirimycin, an alpha-1,6-glucosidase inhibitor.

Authors:  M Arai; S Minatoguchi; H Kumada; Y Uno; Y Nishida; K Hashimoto; N Wang; G Takemura; T Fujiwara; M Higashioka; K Kuwano; H Fujiwara
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

6.  Differential effects of calpain inhibitors on hypertrophy of cardiomyocytes.

Authors:  Jay R Pollack; Richard C Witt; Jeffrey T Sugimoto
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

7.  Calpain inhibition attenuates right ventricular contractile dysfunction after acute pressure overload.

Authors:  Clifford R Greyson; Gregory G Schwartz; Li Lu; Shuyu Ye; Steve Helmke; Ya Xu; Hasan Ahmad
Journal:  J Mol Cell Cardiol       Date:  2007-10-23       Impact factor: 5.000

8.  Loss of cardioprotection induced by ischemic preconditioning after an initial ischemic period in isolated rat hearts.

Authors:  Alexandros D Cokkinos; Stylianos Tzeis; Panagiotis Moraitis; Constantinos Pantos; Hariklia Carageorgiou; Dimitrios Panousopoulos; Dennis D Varonos; Dennis V Cokkinos
Journal:  Exp Clin Cardiol       Date:  2003

Review 9.  Calpains, mitochondria, and apoptosis.

Authors:  Matthew A Smith; Rick G Schnellmann
Journal:  Cardiovasc Res       Date:  2012-05-11       Impact factor: 10.787

10.  Calpain inhibition preserves talin and attenuates right heart failure in acute pulmonary hypertension.

Authors:  Hasan A Ahmad; Li Lu; Shuyu Ye; Gregory G Schwartz; Clifford R Greyson
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-10       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.